Is this raise in addition to the loan or to replace it?
The explanation for the loan was that it was for unforesee potential cashflow issues and now we see there are clear foreseen planned expenses.
Does the demand warrant this expenditure? If so, what are the projected sales?
When i bought into this company the flow of information was much better than it is currently.
- Forums
- ASX - By Stock
- UCM
- Ann: Pro rata rights issue
UCM
uscom limited
Add to My Watchlist
5.00%
!
1.9¢

Ann: Pro rata rights issue, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $4.759M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $9.5K | 500K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 94700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 0.014 |
1 | 1351000 | 0.013 |
2 | 215603 | 0.012 |
2 | 400099 | 0.010 |
1 | 150000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 46000 | 1 |
0.020 | 63256 | 1 |
0.021 | 24866 | 1 |
0.022 | 6549 | 1 |
0.055 | 95083 | 2 |
Last trade - 11.08am 25/06/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online